March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Monitoring Of Patients On Hydroxychloroquine For At Least Five Years: A follow-up Of 21 Patients
Author Affiliations & Notes
  • Danielle Amana
    Department of Ophthalmology, Orleans Hospital, Orleans, France
  • Isabelle Ingster-Moati
    Ophthalmology, University Paris 7 Diderot, Necker Hospital, Paris, France
  • Eliane Albuisson
    Biostatistics Department, University of Medicine, Vandoeuvre-les-Nancy, France
  • Caroline Girard
    Department of Ophthalmology, University Hospital, Besancon, France
  • Bernard Delbosc
    Department of Ophthalmology, University Hospital, Besancon, France
  • Footnotes
    Commercial Relationships  Danielle Amana, None; Isabelle Ingster-Moati, None; Eliane Albuisson, None; Caroline Girard, None; Bernard Delbosc, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5725. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Danielle Amana, Isabelle Ingster-Moati, Eliane Albuisson, Caroline Girard, Bernard Delbosc; Monitoring Of Patients On Hydroxychloroquine For At Least Five Years: A follow-up Of 21 Patients. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5725.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To analyze functional and anatomic retinal changes in patients treated with hydroxychloroquine for at least five years.

Methods: : 21 patients on hydroxychloroquine and 21 controls were included in this study between May and December 2010. Patients were divided into sub-groups according to daily hydroxychloroquine intake ( ≤ 6, 5 mg/ideal weight/day or > 6,5 mg/ideal weight/day) and cumulative doses (< 1000g or > 1000g). All patients were clinically asymptomatic and underwent a complete ophthalmologicexamination as well as the following tests: central 10° visual field, fundus autofluorescence (AF) imaging, Spectral Domain optical coherence tomography (SD OCT) and multifocal electroretinogram (mfERG). All controls underwent a complete ophthalmologic examination and SD OCT. We analyzed the macular ganglion cell complex (mGCC) on SD OCT.

Results: : The average amplitude of the P1 wave of the 2 - 5° central ring was lower (p<0.03) in the patient sub-group cumulative dose >1000g than in the sub-group cumulative dose <1000g. There was no statistically significant difference in the average values of the P1 wave amplitude on mf ERG between sub-group daily dose ≤6.5mg/ideal weight/day and sub-group daily dose >6.5mg/ideal weight/day. The mfERG ring ratios were also compared including R1/R2, R1/R3, R1/R4, R1/R5, R1/R6. No statistically significant difference was found in mfERG ring ratios between the patient sub-group cumulative dose >1000g and the sub-group cumulative dose <1000g or the sub-group daily dose ≤6.5mg/ideal weight/day and the sub-group daily dose >6.5mg/ideal weight/day. All patients had a normal photoreceptor inner segment-outer segment junction line on SD OCT. No statistically significant difference was observed in average retinal thickness values of the macular ganglion cell complex between patient group and control group. However, the correlation analysis seems to provide additional information (significant and positive correlations for controls become no significant and negative for patients) that may be included in the results and which show the potential value of SD OCT.

Conclusions: : We detected some elements of changes with SD OCT and mfERG but not clearly toxicity.

Keywords: drug toxicity/drug effects • retina • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×